Thereâs been plenty of insider buying among S&P/ASX 200 Index (ASX: XJO) shares this week, with one director snapping up a whopping $198,000 stake in their company.
Letâs take a closer look at all the action going down among market favourites.
6 ASX 200 directors buying their own companies’ shares
The spotlight might be on ASX 200 lithium share Allkem Ltd (ASX: AKE) this week after the companyâs chair Peter Coleman snapped up a sizeable chunk of its securities.
He bought 17,054 Allkem shares between Friday and Tuesday, paying an average of around $11.61 apiece to more than double his holding. That equals a total spend of nearly $198,000.
The buying spree saw the boss bolstering his stake for a bargain price if Goldman Sachs is to be believed. The top broker tipped the Allkem share price to soar to $15.40 earlier this week, as my Fool colleague James reports.
Also the subject of insider buying this week is Charter Hall Retail REIT (ASX: CQR). The real estate investment trustâs (REITâs) chair Roger Davis bought 38,669 units for around $3.98 apiece on Monday.
Over at banking giant Commonwealth Bank of Australia (ASX: CBA), director Anne Templeman-Jones was buying. She snapped up 300 shares for an average price of $101.10 apiece.
Meanwhile, Bapcor Ltd (ASX: BAP) saw not one, but two board members buying up its shares this week.
Chair Margaret Anne Haseltine bought 7,515 shares for $6.65 apiece while director Brad Soller bought 7,500 for the slightly higher price of $6.66 apiece.
Gold miner Regis Resources Ltd (ASX: RRL) has also seen insider buying this week. Director Paul Arndt bought into the company on Tuesday, acquiring 9,273 shares for a total of around $15,857, or approximately $1.71 apiece.
And finally, Healius Ltd (ASX: HLS) chair Jenny McDonald bolstered her stake in the pathology giant, buying 37,500 shares for $2.751 apiece â a total spend of around $103,000.
The post 6 ASX 200 directors buying up their companiesâ shares this week appeared first on The Motley Fool Australia.
FREE Beginners Investing Guide
Despite what some people may say – we believe investing in shares doesn’t have to be overwhelming or complicated…
For over a decade, we’ve been helping everyday Aussies get started on their journey.
And to help even more people cut through some of the confusion “experts’” seem to want to perpetuate – we’ve created a brand-new “how to” guide.
Yes, Claim my FREE copy!
*Returns as of March 1 2023
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- An insider just loaded up on Allkem shares: Should you buy into this lithium giant?
- 4 ASX 200 lithium shares to buy now: broker
- 5 things to watch on the ASX 200 on Thursday
- Watch out CBA: This ASX 200 bank share is rapidly growing
- Here are the top 10 ASX 200 shares today
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has recommended Bapcor. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/FKdZLj7
Stock Pick 